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A B S T R A C T
Introduction: Premutation carriers of the FMR1 gene are at risk of developing fragile X-associated tremor/ataxia
syndrome (FXTAS), a neurodegenerative disease characterized by motor, cognitive, and psychiatric decline as
well as cerebellar and cerebral white matter pathology. Several studies have documented preclinical sensor-
imotor issues in aging premutation carriers, but the extent to which sensorimotor brain systems are affected and
may represent early indicators of atypical neurodegeneration has not been determined.
Materials and methods: Eighteen healthy controls and 16 FMR1 premutation carriers (including five with pos-
sible, probable, or definite FXTAS) group-matched on age, sex, and handedness completed a visually guided
precision gripping task with their right hand during fMRI. During the test, they used a modified pinch grip to
press at 60% of their maximum force against a custom fiber-optic transducer. Participants viewed a horizontal
white force bar that moved upward with increased force and downward with decreased force and a static target
bar that was red during rest and turned green to cue the participant to begin pressing at the beginning of each
trial. Participants were instructed to press so that the white force bar stayed as steady as possible at the level of
the green target bar. Trials were 2-sec in duration and alternated with 2-sec rest periods. Five 24-sec blocks
consisting of six trials were presented. Participants’ reaction time, the accuracy of their force relative to the
target force, and the variability of their force accuracy across trials were examined. BOLD signal change and
task-based functional connectivity (FC) were examined during force vs. rest.
Results: Relative to healthy controls, premutation carriers showed increased trial-to-trial variability of force
output, though this was specific to younger premutation carriers in our sample. Relative to healthy controls,
premutation carriers also showed reduced extrastriate activation during force relative to rest. FC between ip-
silateral cerebellar Crus I and extrastriate cortex was reduced in premutation carriers compared to controls.
Reduced Crus I-extrastriate FC was related to increased force accuracy variability in premutation carriers.
Increased reaction time was associated with more severe clinically rated neurological abnormalities.
Conclusions: Findings of reduced activation in extrastriate cortex and reduced Crus I-extrastriate FC implicate
deficient visual feedback processing and reduced cerebellar modulation of corrective motor commands. Our
results are consistent with documented cerebellar pathology and visual-spatial processing in FXTAS and pre-
symptomatic premutation carriers, and suggest FC alterations of cerebellar-cortical networks during sensor-
imotor behavior may represent a “prodromal” feature associated with FXTAS degeneration.
1. Introduction
Premutation alleles of the FMR1 gene involving 55–200 cytosine-
guanine-guanine (CGG) repeats confer risk for development of fragile X-
associated tremor/ataxia syndrome (FXTAS) among aging individuals
(> 50 years of age). FXTAS is a neurodegenerative disorder
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characterized by motor symptoms, including kinetic tremor and gait
ataxia, radiological signs, including generalized brain atrophy, white
matter pathology in the middle cerebellar peduncles (MCP) and other
brain regions, as well as multiple associated clinical issues (Jacquemont
et al., 2003). Molecular and demographic characteristics associated
with increased FXTAS penetrance among premutation carriers have
been identified, including increased age, increased CGG repeat length,
increased mRNA transcript, and being male (Jacquemont et al., 2004;
Leehey et al., 2008; Vittal et al., 2018; Hoem et al., 2019). The pre-
dictive value of these markers remains limited, however, and FXTAS
often goes undiagnosed or diagnosed only during latter stages when
symptoms become more difficult to manage (Hall et al., 2005).
FXTAS symptom presentation and timing are variable, and several
studies have suggested that a “prodromal” phase, characterized by
structural brain changes and subclinical social-emotional, cognitive,
and motor issues may be detectable prior to clinically-observable
symptoms (Wang et al., 2012; Loesch et al., 2015; Gossett et al., 2016;
Wang et al., 2017; McKinney et al., 2019; Park et al., 2019). Quanti-
tative markers of core sensorimotor and brain system differences re-
presenting prodromal FXTAS are needed to better understand disease
course, identify degenerative processes during early stages, and to track
and eventually mitigate disease progression, as has been done in other
neurological disorders (Rowe et al., 2010; González-Garcia et al., 2011;
Trujillo et al., 2015).
Multiple quantitative studies have documented sensorimotor issues
in asymptomatic aging FMR1 premutation carriers, suggesting that
precise sensorimotor measurements may hold promise for identifying
neurodegenerative processes associated with prodromal FXTAS.
Atypical postural control has been demonstrated in premutation car-
riers without FXTAS, including increased postural sway when presented
with conflicting visual information, implicating deficits in the integra-
tion of multi-sensory feedback inputs during motor behavior (O'Keefe
et al., 2015). Reduced complexity of postural sway also has been de-
monstrated and is associated with increased CGG repeat length in
asymptomatic premutation carriers, indicating quantitative sensor-
imotor measurements may track with disease risk (O'Keeffe et al., 2019;
Wang et al., 2019). Similarly, using tests of precision manual force, we
recently documented increased motor variability in aging premutation
carriers (between 44 and 77 years of age; Park et al., 2019) and reduced
motor complexity associated with more severe clinical motor issues and
increased CGG repeats (McKinney et al., 2019). Findings that deficits of
precision manual motor control are associated with both molecular and
clinical indicators of FXTAS in premutation carriers with subclinical
presentations suggest that quantifiable differences in manual motor
behavior may represent prodromal features of the disease. Clarifying
functional brain differences associated with manual motor behavioral
issues in premutation carriers may help determine new targets for
identifying degeneration early in its course, similar to other diseases in
which neurobiological changes can be detected prior to behavioral and
clinical decline (Sommer et al., 2004; Remy et al., 2005; Unschuld
et al., 2012; Dillen et al., 2017).
Manual motor control is supported by a discrete network of cortical,
cerebellar, and basal ganglia circuits (Vaillancourt et al., 2003b;
Prodoehl et al., 2009; Spraker et al., 2009). Cerebellar-cortical systems
are selectively involved in reactively adjusting motor output in order to
maintain precision in response to multi-sensory feedback error in-
formation (Stein, 1986; Wolpert et al., 1998). The MCP is the major
cortical-cerebellar input pathway relaying sensory information to cer-
ebellar targets, and hyperintensities of the MCP seen on T2-weighted
MR images are a primary radiological sign of the disease (Jacquemont
et al., 2003; Greco et al., 2006). MCP degeneration and more general-
ized cerebellar atrophy may occur before the onset of tremor, ataxia or
other neurological symptoms in premutation carriers (Brunberg et al.,
2002; Wang et al., 2017), and reduced MCP width is seen in both
asymptomatic premutation carriers and those with FXTAS (Famula
et al., 2018; Shelton et al., 2018). Further, reductions in extreme
capsule pathway connectivity (Wang et al., 2012) and superior cere-
bellar peduncle (SCP) tract volume are associated with increased CGG
repeats and disease risk (Wang et al., 2013), suggesting that white
matter pathways integrating sensorimotor brain networks are affected
by FXTAS and may show degenerative changes prior to disease onset.
Task-based functional MRI studies hold particular promise for
tracking disease associated neurodegeneration as they are sensitive to
subtle changes in brain function and strongly related to clinical trait
dimensions (Paulsen et al., 2004; Carmichael et al., 2018; Greene et al.,
2018). Previous fMRI studies comparing asymptomatic premutation
carriers to healthy controls have identified reduced brain activation in
premutation carriers, including reduced activation in the right tem-
poroparietal junction during a temporal working memory task (Kim
et al., 2014) and reduced activation in ventral and dorsal inferior
frontal cortices during a verbal working memory task (Hashimoto et al.,
2011a). Reduced activation in both of these studies was shown to be
associated with molecular markers known to contribute to FXTAS in-
cluding increased CGG repeat length and elevated levels of FMR1
mRNA, highlighting the utility of fMRI studies in linking molecular
markers to downstream brain system dysfunction. Although sensor-
imotor deficits are frequently observed in premutation carriers with and
without FXTAS, only one known task-based functional MRI study has
investigated sensorimotor control in aging premutation carriers. Brown
and colleagues reported reduced activation in cerebellar lobules V-VI in
asymptomatic premutation carriers during visually-guided sequential
finger tapping (Brown et al., 2018). These findings suggest cerebellar
dysfunction during manual motor behavior may represent a quantifi-
able trait dimension associated with atypical aging in premutation
carriers and putative FXTAS risk. It remains unclear whether these
findings reflect intrinsic defects of cerebellar function or atypical cer-
ebellar-cortical functional connectivity as implicated by deterioration
of cortical-cerebellar tracts, including the MCP and SCP, and findings of
generalized white matter pathology in aging premutation carriers
(Brunberg et al., 2002; Ariza et al., 2016; Sellier et al., 2017; Famula
et al., 2018). Analyses of the relationships between cortical-cerebellar
connectivity and precision manual motor control in aging premutation
carriers are needed to clarify the functional anatomy of manual motor
behavioral differences in premutation carriers and determine functional
brain markers associated with the FXTAS prodrome.
In the present fMRI study, we examined cerebellar-cortical function
and connectivity in aging FMR1 gene premutation carriers performing a
test of visually guided precision grip force. Consistent with our prior
studies (McKinney et al., 2019; Park et al., 2019), we expected FMR1
premutation carriers to show reduced force accuracy and greater force
variability across trials relative to controls. We also hypothesized aty-
pical sensory cortical and cerebellar activation and reduced cerebellar-
cortical functional connectivity in premutation carriers. Sensorimotor
behavior, cerebellar-cortical function, and cerebellar-cortical con-
nectivity were analyzed in relation to CGG repeat length and clinical
measures of neuromotor behavior to determine the extent to which
these quantitative markers may covary with disease risk or progression.
2. Materials and methods
2.1. Participants
Sixteen FMR1 premutation carriers and 18 healthy controls com-
pleted a visually-guided precision gripping task with their right hand
during fMRI. Premutation carriers and controls did not differ on age
(FMR1: Median = 57 years, IQR = 48–64; Controls: Median =
55 years, IQR = 46.5–64.5; t(32) = 0.16, p = .877), sex ratio (FMR1:
25% male (N = 4); Controls: 44% male (N = 8); χ2 = 1.40, p= .236),
handedness (FMR1: 94% right-handed (N = 15); Controls: 83% right-
handed (N = 15); χ2 = 0.89, p = .347), full-scale IQ (FMR1:
Median = 100, IQR = 94–106; Controls: Median = 106, IQR = 98.5
–119.5; t(31) = 1.99, p = .056), or right hand grip strength (i.e.,
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maximum voluntary contraction, or MVC; FMR1: Median = 39 N,
IQR = 31–54; Controls: Median = 44 N, IQR = 34–54 ; t(32) = 0.12;
p = .904). Based on diagnostic standards, (Jacquemont et al., 2003),
one of 12 premutation carriers who completed a clinical and MRI
evaluation showed signs of “possible” FXTAS, one of 12 met criteria for
“probable” FXTAS, two of 12 met criteria for “definite” FXTAS, and
eight of 12 showed no or insufficient clinical or radiological signs to
meet diagnostic criteria for FXTAS. Of the four premutation carriers
who completed only the MRI and not the clinical evaluation, two
showed minor radiological signs and two showed no radiological signs
of FXTAS. In total, one of 16 premutation carriers showed signs of
“possible” FXTAS, two of 16 met criteria for “probable” FXTAS, two of
16 met criteria for “definite” FXTAS, eight of 16 showed limited clinical
or radiological signs and did not meet FXTAS diagnostic criteria, and
three of 16 were inconclusive because they showed no radiological
signs specific to FXTAS but failed to complete a clinical evaluation.
Clinical characteristics for all individual premutation carriers, including
IQ scores, ICARS ratings, and clinical MRI findings, are provided in
Table A.1.
No premutation carriers had previously received a diagnosis of any
neurological disorder, including FXTAS, and no premutation carrier
self-reportedmotor (e.g., gait ataxia, intention tremor) or memory issues
during a clinical interview with one of the research team members
(MWM). Controls were excluded for current or past neurodegenerative,
neurological, or major psychiatric disorders. Controls also were ex-
cluded for a family history of fragile X syndrome or intellectual/de-
velopmental disabilities in first- or second-degree relatives. Participants
from either group were excluded if they reported any known neurolo-
gical or musculoskeletal disorder associated with atypical sensorimotor
functioning or a history of medications known to affect sensorimotor
functioning, including antipsychotics, stimulants, or benzodiazepines
(Reilly et al., 2008).
FMR1 premutation carriers and healthy controls were identified
using convenience sampling. FMR1 premutation carriers geographically
close enough to participate were identified through local
fragile X clinics and postings on local and national fragile X association
listservs. Control participants were recruited through community ad-
vertisements. All study participants provided informed consent, and all
study procedures were approved by the local Institutional Review
Board and were carried out in accordance with the Declaration of
Helsinki.
2.2. Procedures
Cognitive functioning was assessed using the abbreviated battery of
the Stanford-Binet Intelligence Scales, Fifth Edition (SB-5) including
nonverbal fluid reasoning and verbal knowledge sub-sections (Roid,
2003). One participant did not complete the SB-5 because they were not
fluent in English.
Thirteen premutation carriers provided blood samples to confirm
FMR1 premutation status. Premutation carriers who did not complete a
blood draw provided documentation of prior genetic testing to confirm
premutation carrier status. FMR1 CGG repeat count was quantified
using molecular testing conducted at Dr. Elizabeth Berry-Kravis’
Molecular Diagnostic Laboratory at Rush University. Genomic DNA was
isolated from peripheral blood leukocyte samples. The FMR1 poly-
merase chain reaction (PCR) test with quantification of allele-specific
CGG repeat count was performed using commercially available kits
(Asuragen, Inc., Austin, TX). For female participants, CGG repeat ana-
lyses reflect the longest CGG repeat of the two alleles.
Twelve premutation carriers completed a clinical exam by a neu-
rologist with expertise in movement disorders (PK). The clinical exam
included administration of the International Cooperative Ataxia Rating
Scale (Trouillas et al., 1997). The ICARS is comprised of 19 sections
examining postural and gait disturbances, ataxia, dysarthria and ocu-
lomotor behavior. Higher scores indicate more severe neuromotor
issues. The ICARS has been validated previously for diagnosis of ataxia
in patients with focal cerebellar lesions (Schoch et al., 2007), hereditary
spinocerebellar and Friedrich’s ataxia (Schmitz-Hubsch et al., 2006).
Four premutation carriers did not complete the clinical evaluation due
to scheduling difficulties. T2-weighted MR images were acquired for all
16 premutation carriers to assess radiological signs of FXTAS (PK).
2.3. Force testing
Before completing fMRI testing, each participant's right hand MVC
(calculated in Newtons, or N) was estimated using the average of the
maximum force output during three trials in which they pressed as hard
as they could for three seconds.
During the fMRI test, participants used a modified pinch grip to
press at 60% of their MVC against a custom fiber-optic transducer with
0.025 N resolution (Fig. A.1; Neuroimaging Solutions, Gainesville, FL).
They viewed a horizontal white force bar that moved upward with
increased force and downward with decreased force and a static target
bar that was red during rest and turned green to cue the participant to
begin pressing at the beginning of each trial (Fig. A.1). Participants
received two instructions: (1) press the transducer as quickly as possible
when the red target bar turns green, and (2) keep pressing so that the
force bar stays as steady as possible at the level of the green target bar.
Stimuli were presented on an EPSON PowerLite 7300 projector with a
resolution of 1024 × 768 at a visual angle of 0.623°/N.
During the precision gripping task, five 24-sec blocks consisting of
six trials were presented (30 trials in total). Trials were 2-sec in dura-
tion and alternated with 2-sec rest periods. Runs began with a 24-sec
rest block in which participants viewed the two horizontal bars, but the
bars did not move and participants were instructed not to press. Force
and rest blocks then were alternated for the remainder of the run (total
duration: 4:24).
2.4. Force data processing
Procedures for processing and analyzing force data were similar to
those previously reported (McKinney et al., 2019). Force data were
digitized at 125 Hz by an si425 Fiber Optic Interrogator (Micron Optics,
Atlanta, GA) and converted to Newtons within MATLAB (National In-
struments, Austin, TX). Force data were low-pass filtered with a double-
pass 4th-order Butterworth filter at a 15 Hz cutoff, and analyzed using a
custom algorithm previously developed by our lab and implemented in
MATLAB (Wang et al., 2015). To examine force accuracy, we de-
termined the mean sustained force for each trial and divided by the
target force. Mean sustained force was examined excluding the initial
phase in which individuals increased their force level, and the relaxa-
tion phase in which individuals released their force following the stop
cue. We also examined the standard deviation of force accuracy across
trials (force accuracy variability) and reaction time (RT). RT was cal-
culated as the difference between the onset of gripping (when the rate
of force increase first exceeded 5% of the peak rate of force increase and
remained above this level for at least 100 ms) and the appearance of the
start cue. Trials were excluded for off-task behavior (e.g., failure to grip
after the appearance of the start cue). Premutation carriers and healthy
controls did not differ in the number of valid trials (out of 30 possible
trials) that were included in final analyses (FMR1: mean = 29.6 trials,
SD = 1.5 trials; Controls: mean = 28.8 trials, SD = 2.2 trials; t
(32) = −1.22, p = .233).
2.5. fMRI data acquisition
Magnetic resonance images were collected using a 3.0 T Phillips
Achieva scanner with a 32-channel head coil. Anatomical images were
obtained using a high-resolution T1-weighted MPRAGE sequence
(TR = 8.1 ms; TE = 3.73 ms; flip angle = 12°; FOV = 256
× 204 mm2; 160 slices; voxel size = 1 mm3). fMRI data was acquired
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using a T2*-weighted single shot, gradient-echo echo-planar pulse se-
quence: TR = 2000 ms; TE = 30 ms; flip angle = 60°;
FOV = 220 mm2; matrix = 64 × 64; 36 slices; voxel size = 3 × 3
× 4 mm3. The following T2-weighted sequences was used to evaluate
radiological signs of FXTAS: TR = 6350 ms; TE = 100 ms; flip
angle = 120°; FOV = 256 × 256 mm2; 78 slices; voxel
size = 1 × 1 × 2 mm3.
2.6. fMRI processing
All imaging data was processed using the Analysis of Functional
Neuroimages (AFNI; https://afni.nimh.nih.gov/) software suite.
Anatomical images were first uniformized, skull-stripped, and non-
linearly warped to MNI standard space (MNI152) using the @SSwarper
program. The first five volumes of each functional run were discarded
to allow for magnetization equilibration. Slice-timing correction was
applied using standard AFNI procedures, and consecutive volumes
with> 0.5 mm of movement were discarded. All participants had<
13% of their volumes discarded due to motion, and premutation car-
riers and healthy controls did not differ in the percentage of TRs cen-
sored (FMR1: mean = 2.2%, SD = 3.9%; Controls: mean = 1.0%,
SD = 3.9%; t(32) = −1.20, p= .238), average motion per TR (FMR1:
mean = 0.12 mm, SD = 0.07 mm; Controls: mean = 0.12 mm,
SD = 0.05 mm; t(32) = −0.03, p = .976), or maximum motion dis-
placement (FMR1: mean = 1.46 mm, SD = 0.64 mm; Controls:
mean = 1.59 mm, SD = 0.89 mm; t(32) = 0.47, p= .644). Remaining
volumes were aligned to the nonlinearly warped, skull-stripped anato-
mical image using the minimum outlier volume (i.e., volume with the
least movement) as a reference. Volumes were spatially smoothed to a
full-width half-maximum of 5 mm and scaled to the mean voxel time-
series values of 100. Regression analyses (3dDeconvolve and 3dREML)
for each subject used a standard block function while regressing out six
motion parameters and their first derivative (x, y, z, pitch, roll, yaw).
Regression BOLD signal outcomes represent percent signal change of
the relevant contrast (β) and associated t-statistics.
2.7. Behavioral analysis
Linear regression analyses were conducted to compare FMR1 pre-
mutation carriers and controls on force outcomes (i.e., RT, force accu-
racy, and force accuracy variability). Models included terms for group
and age as well as a group × age interaction term. Age was transformed
to z-scores using the grand mean for all models, and group was dummy
coded with healthy controls serving as the baseline reference. Two non-
normally distributed behavioral outcomes, MVC and RT, were natural
log-transformed. All regression analyses were conducted using the stats
package within R (Version 3.6.0), and effect size estimates were ob-
tained using the sjstats package (Lüdecke, 2019).
2.8. Imaging analysis
A context-dependent correlation analysis (psychophysiological in-
teraction, or PPI; Friston et al., 1997; McLaren et al., 2012) was used to
compare changes in whole brain-cerebellar connectivity between
groups as a function of task. Separate PPI analyses were conducted for
six cerebellar seed ROIs selected based on results of prior fMRI studies
of similar precision gripping tests (Vaillancourt et al., 2006; Neely et al.,
2013): left and right Crus I, Crus II, and lobules V + VI. Cerebellar
seeds were defined using the SUIT cerebellar atlas (Diedrichsen, 2006).
Individuals’ preprocessed images were analyzed using a GLM con-
taining predictors for the Force and Rest blocks (modelled using a ca-
nonical HRF), the seed timeseries, Force × seed and Rest × seed PPI
regressors, 12 motion regressors (six rotations/translations and their
first derivatives), and a second-order orthogonal polynomial. PPI re-
gressors were calculated as the interaction between the estimated
neural signal from the seed region (by deconvolving the HRF) and the
Force task or Rest timeseries, which was then reconvolved with the
HRF. The resulting contrast images were entered into a second-level
group analysis with participant as a random effect to compare the beta
weights of the two PPI regressors. Individual effect size estimates from
each cluster were obtained using a leave-one-subject-out approach to
preserve independence of ROI localization and estimation (Esterman
et al., 2010). Specifically, for each individual, a GLM excluding that
participant (using the same thresholds as the whole-group analysis) was
used to localize an ROI from which that individual’s mean values were
extracted.
The AFNI programs 3dttest++ and 3dMEMA were used to create
separate group statistics maps and a group contrast statistics map. In
light of recent concerns regarding false-positive rates in fMRI research
(Eklund et al., 2016), best-practice recommendations from AFNI (Cox
et al., 2017) were applied using the auto-correlation function (ACF)
function within the 3dClustSim program to correct for multiple com-
parisons and false positive clusters. In short, simulated noise-only vo-
lumes using ACF blur values were created, thresholded, and clustered,
providing recommended cluster-size thresholds (denoted as α) to use
for given voxel-wise thresholds (denoted as p). All fMRI analyses used a
second nearest-neighbor (NN2) and bi-sided thresholding method.
Using these methods, we present results for a family-wise error rate of
p < .01 and cluster-size threshold of α < 0.05 (> 49 voxels for ac-
tivation differences;> 81 voxels for PPI analyses), as well as family-
wise error rate of p < .005 and cluster-size threshold of α < 0.05
(> 32 voxels for activation differences or> 44 for PPI analyses). After
the identification of activation and connectivity clusters, linear re-
gression models including diagnostic group, age, and a group × age
interaction term as predictors were used to assess whether age-related
differences in brain activation or connectivity differed between groups.
2.9. Brain-behavior analyses
To determine the relationship between age, force-related activation,
force-related connectivity, and force behavior, separate linear regres-
sion analyses were conducted for RT, force accuracy, and force accu-
racy variability. For each model, diagnostic group was included as a
predictor and brain activations that were different between premuta-
tion carriers and controls were included as predictors along with the
group × brain region, age × brain region, and group × brain re-
gion × age interaction terms. Separate models were constructed for
cerebellar-cortical networks identified in group PPI comparisons. A
Holmes sequential Bonferroni procedure was used to calculate stepwise
adjustments to the target alpha level (0.05) to control for Type I error.
Due to the small number of males in our premutation carrier sample
(N = 4), we did not examine sex differences or interactions. Participant
sex is indicated in figures to provide case-level information.
We also assessed the relationship between force behavior, brain
activation and connectivity, and CGG repeat length as well as clinical
ratings of neurological abnormalities (ICARS total score). Due to the
non-normal distribution of CGG repeat length and ICARS scores, the
relationships between these variables, force data, BOLD signal change,
and PPI outcomes were examined using Spearman’s rank-order corre-
lations. Correlational results with p < .05 are interpreted as sig-
nificant. Correlational analyses were conducted using IBM SPSS
Statistics 25.
3. Results
3.1. Precision force control in FMR1 premutation carriers and controls
Premutation carriers and healthy controls showed similar MVCs
(Table A.2; β = −0.025, SE = 0.128, p= .845, η2 = 0.001). Age was
associated with MVC in healthy controls (β = −0.179, SE = 0.086,
p = .045, η2 = 0.003), though the relationship between age and MVC
was different between groups (group × age: β = 0.368, SE = 0.132,
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p = .009, η2 = 0.206). For healthy controls, increased age was asso-
ciated with lower MVCs, whereas increased age was associated with
higher MVCs for premutation carriers.
Premutation carriers and healthy controls showed similar RTs
(Table A.2; β = 0.046, SE = 0.077, p= .555, η2 = 0.011). Age was not
significantly related to RT in healthy controls (β = 0.036, SE = 0.051,
p = .495, η2 = 0.005), and the relationship between age and RT was
similar across groups (group × age: β = −0.048, SE = 0.079,
p = .546, η2 = 0.012).
Visual and statistical inspection of the distribution of force accuracy
values identified one significant outlier (> 4 standard deviations below
the grand mean; Cook’s distance D = 0.73) which was excluded from
subsequent force accuracy analyses. Premutation carriers and healthy
controls showed similar levels of force accuracy (Table A.2;
β = −0.004, SE = 0.008, p = .586, η2 = 0.012). Age was not sig-
nificantly related to levels of force accuracy in healthy controls
(β = 0.003, SE = 0.005, p = .549, η2 = 0.013), and the relationship
between age and force accuracy was similar across groups
(group × age: β = −0.014, SE = 0.008, p = .091, η2 = 0.093).
Overall, premutation carriers and healthy controls showed similar
levels of force accuracy variability (Table A.2; β = 0.009, SE = 0.007,
p = .171, η2 = 0.048). Age was associated with force accuracy varia-
bility in healthy controls (β = 0.011, SE = 0.004, p = .021,
η2 = 0.010), though the relationship between force accuracy variability
and age varied as a function of group (Fig. A.2; group × age:
β = −0.021, SE = 0.007, p = .005, η2 = 0.217). Increased age was
associated with reduced force accuracy variability in premutation car-
riers and increased force accuracy variability in healthy controls. On
average, premutation carriers under 60 years of age showed greater
variability relative to healthy controls under 60 years of age, whereas
older premutation carriers showed less variability than older controls.
3.2. Brain activation during force in FMR1 premutation carriers and
controls
Relative to healthy controls, premutation carriers showed reduced
force-dependent activation in extrastriate cortex extending from cuneus
to lingual gyrus (Fig. A.3; MNI [1, −86, 7]; k= 54 voxels; β = 0.909).
Healthy controls demonstrated greater extrastriate BOLD activation
during force relative to rest (β = 0.643, p < .01), whereas premuta-
tion carriers showed similar activation across force and rest
(β = −0.266, p > .25). When using a more stringent voxel-wise
threshold (p < .005), this cluster was reduced to 31 voxels and sig-
nificant only at a cluster-size threshold of α < 0.06. Differences be-
tween groups in extrastriate activation varied as a function of age
(group × age interaction: β = 0.402, SE = 0.140, p = .008,
η2 = 0.142). Increased age was associated with reduced extrastriate
activation in controls, but increased extrastriate activation in premuta-
tion carriers (Fig. A.4).
3.3. Cerebellar-cortical connectivity in FMR1 premutation carriers and
controls
Force-dependent changes in functional connectivity between right
Crus I and extrastriate cortex (MNI [−4, 56, −2]; k = 58 voxels;
p < .005, α < 0.03) differed between groups (Fig. A.5); healthy
controls showed increased Crus I-extrastriate connectivity during force
compared to rest, while premutation carriers showed a decrease in Crus
I-extrastriate connectivity during force compared to rest. When using a
more relaxed voxel-level threshold (p < .01), the cluster increased in
size to 75 voxels but failed to survive cluster-size thresholding
(α < 0.06). Age was not associated with Crus I-extrastriate con-
nectivity during force (β = 0.489, SE = 0.656, p = .462, η2 = 0.018)
or rest (β = 0.418, SE = 0.637, p = .517, η2 = 0.014). Within-group
comparisons of task-dependent right Crus I connectivity are presented
for controls and premutation carriers in Supplementary Fig. B.1. No
other cerebellar-cortical connectivity differences were seen in com-
parisons of premutation carriers and healthy controls.
3.4. Cerebellar-cortical connectivity and force control
The relationships between force accuracy variability and right Crus
I-extrastriate connectivity during both rest and force was different be-
tween premutation carriers and healthy controls (group × rest:
β = −0.013, SE = 0.004, p = .001, η2 = 0.252; group × force:
β = −0.012, SE = 0.004, p = .002, η2 = 0.224); increased con-
nectivity during both rest and force was related to reduced force ac-
curacy variability in premutation carriers but not in healthy controls
(Table A.3; Fig. A.6). No other significant relationships between age,
force behavior, and brain activation or connectivity were identified.
3.5. Relationships with CGG repeat length and clinical outcomes
Correlations between force outcomes, brain activation, brain con-
nectivity, CGG repeat length and clinically rated neurological ab-
normalities are presented in Table A.4. Greater RTs were associated
with more severe clinically rated neurological abnormalities
(ρ = 0.657, p = .020). Greater force accuracy variability (ρ = 0.366,
p = .219) and reduced Crus I – extrastriate connectivity during force
(ρ = −0.308, p = .306) each were modestly associated with greater
CGG repeat length in premutation carriers, though these relationships
were not significant. No other force or brain function outcomes were
associated with neurological abnormalities. Neither neurological ab-
normalities nor brain outcomes were associated with age.
4. Discussion
Conducting the first known task-based functional MRI study of
cerebellar-cortical connectivity in aging FMR1 premutation carriers, we
document four key findings. First, premutation carriers showed in-
creased force accuracy variability relative to controls, though this dif-
ference was specific to younger premutation carriers in our sample. In
the context of a cross-sectional sample, these results suggest that aging
FMR1 premutation carriers who have remained largely asymptomatic
at> 60 years of age may be less susceptible to precision motor defi-
ciencies. Second, we document reduced extrastriate activation in aging
premutation carriers relative to healthy controls during precision
manual motor control indicating atypical sensorimotor behavior in
premutation carriers may reflect abnormal processing of visual feed-
back. Consistent with our behavioral results, we also found that re-
ductions in extrastriate activation among premutation carriers were
age-dependent and may represent a key predictor of FXTAS vulner-
ability. Third, premutation carriers demonstrated reduced cerebellar
Crus I-extrastriate functional connectivity implicating deficiencies
within cortical-cerebellar networks involved in dynamically adjusting
motor behavior in response to visual feedback information. Our results
showing that reduced Crus I-extrastriate connectivity is related to
greater force accuracy variability in premutation carriers indicates that
these neural system differences are directly linked with reduced con-
sistency of manual motor behavior. Last, slower RTs in premutation
carriers were related to clinical ratings of neuromotor issues indicating
that reduced capacity to rapidly execute precision manual motor ac-
tions may represent an objective and quantitative marker of clinical
neurological abnormalities indicative of FXTAS.
4.1. Precision motor behavior in aging FMR1 premutation carriers
We document that aging premutation carriers show increased pre-
cision force variability relative to controls, though only during the
younger ages studied here, implicating deficient sensory feedback
processing of error information and alterations of motor control pro-
cesses involved in dynamically adjusting output in response to error
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information. These results are consistent with our prior findings of in-
creased force variability during sustained motor action in premutation
carriers (Park et al., 2019). Our finding that elevated force variability is
specific to younger premutation carriers reflects an age-associated im-
provement in motor control (i.e., lower force accuracy variability) in
premutation carriers that contrasts age-associated declines seen in our
control sample and documented previously in healthy aging (Laidlaw
et al., 2000; Vaillancourt et al., 2003a; Vaillancourt and Newell, 2003).
In the context of our cross-sectional data, it is likely that these results
highlight important differences between relatively younger and older
asymptomatic premutation carriers in susceptibility to FXTAS degen-
eration. While FXTAS penetrance increases with age in premutation
carriers, it is possible that the older premutation carriers in our sample
possess background and behavioral characteristics that are protective
against FXTAS as has been suggested previously (Steyaert et al., 1994;
Goodrich-Hunsaker et al., 2011; McKinney et al., 2019). This is con-
sistent with survival biases frequently observed in cross-sectional stu-
dies, in which disease-related mortality leads to the recruitment of a
preponderance of individuals who are at risk for a disease but who are
at lower risk for disease-related mortality (Anderson et al., 2011). The
high proportion of female premutation carriers in our sample also may
contribute to these findings as females are less susceptible to FXTAS
(Rodriguez-Revenga et al., 2009) and demonstrate reduced clinical
symptom severity (Berry-Kravis et al., 2003). Longitudinal studies of
sensorimotor control in male and female premutation carriers are
needed to characterize sex-specific aging profiles and determine factors
that may protect against FXTAS risk and degeneration.
4.2. Cerebellar-cortical functions during precision motor behavior
We document reduced extrastriate activation in aging premutation
carriers relative to controls during sensorimotor behavior implicating re-
duced modulatory output of extrastriate cortex or reduced translation of
initial visual processing from primary visual cortex (striate cortex, or V1).
During goal-directed behavior, extrastriate cortical areas modulate initial
visual input to facilitate attentional selection of visual stimuli by amplifying
and diminishing activity in striate cortex. Reduced activation of extrastriate
cortex in premutation carriers may reflect difficulties attending to and
processing basic visual input during rapid motor action. These findings
extend the one known prior fMRI study of motor behavior in premutation
carriers to indicate that decreased modulation of precision motor behavior
in premutation carriers is associated with reduced processing of sensory
feedback information (Brown et al., 2018). We also found that extrastriate
functional differences in premutation carriers were age-dependent; in-
creased age was associated with increased extrastriate activation in pre-
mutation carriers, but reduced extrastriate activation in controls. These
findings suggest extrastriate hypoactivation during sensorimotor behavior
may be an important marker of FXTAS vulnerability among aging pre-
mutation carriers whereas older premutation carriers who have not shown
any signs of degeneration may represent a more resilient subgroup char-
acterized by more “normative” patterns of aging. As the majority of our
sample was female, these findings also may indicate that older female
premutation carriers in our sample, who are less likely to develop FXTAS
given that they are female and beyond the median age of FXTAS onset (i.e.,
~60 years), may be resistant to the severe degeneration seen in FXTAS.
Longitudinal studies are needed to characterize aging processes of sensor-
imotor brain network functions in male and female premutation carriers.
Reduced extrastriate activation in premutation carriers may reflect
structural degeneration of posterior medial cortical circuits including ex-
trastriate and white matter input pathways to extrastriate cortex, such as
optic radiations or posterior splenium. Initial visual input is transmitted to
visual cortices through projections from lateral geniculate nucleus via the
geniculo-striatal pathway (Rathbun and Usrey, 2009). Impaired visual
motion processing has been documented in premutation carriers (Kéri and
Benedek, 2009; 2012), suggesting pathology within geniculo-striatal mag-
nocellular pathways may contribute to reductions in downstream
extrastriate activation. Reduced extrastriate activation in our sample also is
consistent with findings of degeneration of the splenium of the corpus
callosum in aging premutation carriers. During visual processing, inter-
hemispheric striate and extrastriate visual information converge within the
splenium (Dougherty et al., 2005). Hyperintensities within the splenium
have been observed in individuals with FXTAS, especially females (Adams
et al., 2007; Apartis et al., 2012). Our finding of reduced extrastriate acti-
vation in our largely female sample of premutation carriers may reflect
alterations in posterior splenium projections that interfere with sensor-
imotor behavior. Our study did not include a large enough sample of male
premutation carriers to systematically assess sex differences in brain acti-
vation, but larger studies comparing male and female premutation carrier
brain activation during sensorimotor behavior and visual processing are
warranted.
We also provide novel evidence that precision sensorimotor differences
in aging premutation carriers are associated with reduced cerebellar Crus I-
extrastriate (BA 18/19) connectivity. During sensorimotor action, visual
input is processed in V1 before extrastriate cortical areas encode stimulus
features including shape, color, form and motion information (Hampson
et al., 2004; Born and Bradley, 2005; Arcaro and Kastner, 2015). These
circuits have reciprocal connections with posterior parietal cortex (PPC) and
inferior temporal association areas (Colby et al., 1988; Baizer et al., 1991)
where higher-level information, including spatial and featural information,
respectively, is processed and relayed to cerebellum. The medial extrastriate
target we identified in our group findings also has been shown to integrate
multimodal information, including different sensory inputs that may be
relayed to cerebellum to guide refinements of ongoing motor behavior
(Glickstein et al., 1985; Macaluso et al., 2002). Differences between sensory
feedback information and the efferent copy transmitted from M1 to cere-
bellum are computed within cerebellar cortex, and the refined motor
command is translated to PPC and M1 to modify motor output and improve
the accuracy of subsequent action (Stein and Glickstein, 1992; Glickstein,
2000; Vaillancourt et al., 2003b). Our findings of reduced extrastriate ac-
tivation and Crus I-extrastriate connectivity in premutation carriers in-
dicates deficient processing of multi-sensory feedback and communication
between sensory processing circuits and cerebellum. Our specific result that,
relative to healthy controls, premutation carriers demonstrated reductions
in Crus I-extrastriate connectivity during force relative to rest implicates a
reduced ability to integrate multiple cortical-cerebellar pathways during
sensorimotor behavior. Importantly, reduced Crus I-extrastriate connectivity
was strongly related to reduced force accuracy variability in premutation
carriers whereas extrastriate activation was not associated with sensor-
imotor behavior, suggesting cerebellar-cortical connectivity may better
capture the neurophysiological substrates of motor decline in premutation
carriers at risk for FXTAS relative to intrinsic activation of local circuits.
Additionally, when examined separately, neither premutation carriers nor
healthy controls demonstrated significant changes in connectivity between
force and rest. It is possible that the relative decrease in Crus I-extrastriate
connectivity during force in premutation carriers compared to healthy
controls is driven by a true reduction in connectivity upon the application of
force in premutation carriers that we were unable to detect due to limited
power in identifying relatively smaller effect sizes (e.g., premutation carrier
within-group percent signal change of −0.549). A true decrease in con-
nectivity upon the application of force in premutation carriers could reflect
cerebellar or splenium degeneration in premutation carriers that disrupts
the integration of cerebellar-cortical processes during sensorimotor control.
Our findings of reduced Crus I-extrastriate connectivity are con-
sistent with prior structural MRI and histopathological studies showing
white matter degeneration in premutation carriers with and without
FXTAS (Greco et al., 2006; Hashimoto et al., 2011b; Famula et al.,
2018). Cortical innervation of cerebellar cortex primarily is translated
via pontine nuclei and MCP. Our findings suggest that frequently
documented MCP degeneration in FXTAS and asymptomatic premuta-
tion carriers may disrupt cortical-cerebellar input processes, including
sensory feedback modulation of motor behavior (Cohen et al., 2006;
Wang et al., 2017; Famula et al., 2018; Shelton et al., 2018). Input to
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cerebellar cortex through MCP pathways occurs through white matter
fiber tracts terminating on dendritic spines of Purkinje cells. Purkinje
cell pathology, including reduced cell number and ubiquitin-positive
intranuclear inclusions, has been documented in post-mortem brain
studies of premutation carriers (Greco et al., 2006; Ariza et al., 2016).
Broadly, our fMRI results suggest that quantifying functional con-
nectivity of cortical-cerebellar pathways during motor behavior may
provide objective approaches for tracking cerebellar and sensorimotor
degeneration in aging premutation carriers and marking putative pro-
dromal neurobiological processes associated with FXTAS.
4.3. Sensorimotor behavior, genetic outcomes, and neurological
abnormalities
We found that the relationships between CGG repeat length and both
force accuracy variability and Crus I-extrastriate functional connectivity
were of medium effect size (r’s > 0.3; Cohen, 1992), though neither were
significant. While it is possible that these relationships were not significant
due to our relatively small sample size, several other factors also should be
considered. First, measures of CGG repeat length may fail to capture
downstream molecular processes that are more strongly linked with sen-
sorimotor and functional connectivity alterations. This is especially notable
in a mixed-sex sample comprised of 75% females who may show variable
activation ratios. Additional measurements including activation ratio,
mRNA transcript, and AGG interruptions will be necessary to identify mo-
lecular mechanisms contributing to sensorimotor and neural system
changes and better estimate disease risk and progression. Second, cross-
sectional measures of force variability and cerebellar-cortical connectivity
may be less sensitive to neurodegenerative processes associated with mo-
lecular markers and FXTAS. While the quantitative behavioral and imaging
approaches described here and those documented previously (O'Keefe et al.,
2016; Wang et al., 2017; Famula et al., 2018; Shelton et al., 2018) show
promise for identifying prodromal markers of FXTAS, longitudinal studies
tracking these outcomes over time in premutation carriers are needed to
determine their prognostic value.
We replicated our prior finding of an association between increased
reaction time and more severe clinically rated neurological abnormalities in
aging premutation carriers, although it should be noted that the premuta-
tion carriers in the present study also participated in our prior behavioral
study (McKinney et al., 2019). Deficits in the rapid execution of precision
manual motor actions may reflect multiple issues including delayed in-
formation processing or action execution at peripheral or central levels
(Soontarapornchai et al., 2008). This is consistent with our prior findings of
reduced motor unit discharge rate (Park et al., 2019). Efficient processing of
sensory information and the transmission of motor commands to initiate
movement also rely on intact white matter structural networks which may
be affected in premutation carriers, as indicated by prior findings of reduced
structural connectivity of white matter motor fiber tracts in FXTAS patients
as well as findings of associations between molecular and genetic markers
and reduced structural connectivity in asymptomatic premutation carriers
(Wang et al., 2013). These results may be related to the bradykinesia pre-
viously documented in FXTAS patients (Niu et al., 2014) and may represent
a distinct motor marker of degeneration relative to the control of precision
output. We used a fixed inter-trial rest interval during our sensorimotor task
in this study suggesting that increased RTs may reflect reduced ability to
anticipate the timing of patterned behavior (Johari and Behroozmand,
2017). Direct comparisons of fixed and variable inter-trial intervals during
rapid motor actions will be important for characterizing predictive motor
processes and their neural substrates in premutation carriers.
4.4. Limitations and future directions
Our study has several limitations that should be addressed in future
work. First, longitudinal studies will aid in determining the value of cere-
bellar-cortical connectivity and our behavioral measurements as prodromal
markers of FXTAS. It is unknown whether these neurological and
biobehavioral markers are specific to premutation carriers who will develop
FXTAS or are present across the majority of premutation carriers. These and
previous results documenting relationships between behavioral measure-
ments and symptom severity, however, suggest that quantifiable markers of
sensorimotor precision track with clinical severity and may serve as early
diagnostic markers (Kraan et al., 2014; O'Keefe et al., 2016; McKinney et al.,
2019; Wang et al., 2019). Larger samples representative of the broad range
of sensorimotor and neurological functioning observed in aging premuta-
tion carriers will help assess which measures are most sensitive to early
decline. Second, studies comparing aging effects on sensorimotor behavior
and brain function in male and female premutation carriers are needed. The
majority of our premutation carrier sample was female, though few quan-
titative studies have assessed sensorimotor behavior in aging female pre-
mutation carriers, and no known fMRI studies have examined sensorimotor
brain function in aging female premutation carriers. Our results indicate
that aging female, and not just male premutation carriers show sensor-
imotor and cerebellar-cortical differences compared to controls. It is pos-
sible that our findings are specific to female premutation carriers, though
we would expect male premutation carriers to show similar or more severe
sensorimotor and cerebellar-cortical differences given that they are more
likely to develop FXTAS and demonstrate sensorimotor and cerebellar de-
generation (Jacquemont et al., 2004; Greco et al., 2006; Coffey et al., 2008).
Prior studies showing that degeneration of the splenium is more common in
female than male premutation carriers (Adams et al., 2007; Apartis et al.,
2012) indicate that mechanisms of sensorimotor deterioration may vary as
a function of sex. Still, our results suggest that our behavioral and brain
markers may be robust to sensorimotor and functional brain differences in
premutation carriers across sex. Third, integration of multiple molecular
markers associated with FXTAS are needed, including mRNA transcript,
RAN, and mitochondrial function (Todd et al., 2013; Sellier et al., 2017;
Isabel Alvarez-Mora et al., 2020). Integration of information across mole-
cular, brain, and behavioral levels will guide more individualized models of
neurodegenerative processes associated with FMR1 premutations, and de-
termine prodromal characteristics associated with FXTAS.
5. Conclusions
Our study indicates that reduced cortical-cerebellar functional
connectivity and sensorimotor precision are associated with aging in
FMR1 premutation carriers. Dysfunction of cortical-cerebellar pathways
may represent early degenerative processes associated with prodromal
FXTAS. FMRI measurements of cortical-cerebellar connectivity during
precision motor behavior appear to be useful, objective outcomes for
tracking distinct aging patterns in premutation carriers in order to
understand degenerative processes and perhaps determine disease risk
as premutation carriers age.
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Radiological findings Jacquemont et al., 2003
categorization
1 48 F 100 – – No signs Inconclusive
2 56 F 100 87 2 Generalized cerebral WM lesion, cerebral atrophy (type 1) Non-FXTAS
3 62 F 115 102 3 Generalized cerebral WM lesion, cerebral atrophy (type 2) Non-FXTAS
4 71 M 103 85 12 MCP sign, generalized cerebral WM lesion, cerebral atrophy (type 3) Definite
5* 46 F 100 – – Mild cerebral WM lesion, dot-like cerebral WM hyperintensities Probable
6 58 M 94 60 4 No signs Non-FXTAS
7 58 M 94 63 2 No signs Non-FXTAS
8 52 F 106 81 5 Cerebral atrophy (type 1) Probable
9 67 F 109 62 2 Mild cerebral WM lesion, dot-like cerebral WM hyperintensities Possible
10 48 F 106 110 5 No signs Non-FXTAS
11 46 F 100 68 0 Mild cerebral WM lesion, dot-like cerebral WM hyperintensities Non-FXTAS
12 64 F 94 80 1 Mild cerebral WM lesion, dot-like cerebral WM hyperintensities, cerebral atrophy (type 2) Non-FXTAS
13 49 F – 55 0 MCP sign Non-FXTAS
14 44 F 100 81 – Mild cerebellar atrophy Inconclusive
15 57 M 61 93 8 MCP sign, cerebral atrophy (type 1), widening of 4th ventricle, cerebellar/brainstem atrophy Definite
16 65 F 106 – – No signs Inconclusive
FSIQ: full-scale IQ; CGG: cytosine-guanine-guanine; ICARS: International Cooperative Ataxia Rating Scale; WM: white matter; MCP: middle cerebellar peduncle;
Jacquemont et al., 2003 criteria are as follows: “definite” – one major clinical sign plus one major radiological sign; “probable” – either one major radiological sign
plus one minor clinical sign or two major clinical signs; “possible” – one major clinical sign plus one minor radiological sign; *Subject 5 did not complete a clinical
evaluation but review of medical records indicated the participant demonstrated both gait ataxia and kinetic tremor (both major clinical signs of FXTAS).
Table A.2
Best fitting linear regression models for sensorimotor behavior group comparisons.
MVC Term Estimate (SE) t(30) η2
Intercept 3.734 (0.088) 42.421* –
Group −0.025 (0.128) −0.197 0.001
Age −0.179 (0.086) −2.087* 0.003
Group × Age 0.368 (0.132) 2.795* 0.206
Reaction time Term Estimate (SE) t(30) η2
Intercept −0.952 (0.053) −17.953* –
Group 0.046 (0.077) 0.597 0.011
Age 0.036 (0.051) 0.691 0.005
Group × Age −0.048 (0.079) −0.611 0.012
Force accuracy Term Estimate (SE) t(29) η2
Intercept 0.992 (0.005) 186.555* –
Group −0.004 (0.008) −0.552 0.012
Age 0.003 (0.005) 0.606 0.013
Group × Age −0.014 (0.008) −1.750 0.093
Force accuracy variability Term Estimate (SE) t(30) η2
Intercept 0.042 (0.005) 9.131* –
Group 0.009 (0.007) 1.402 0.048
Age 0.011 (0.004) 2.437* 0.010
Group × Age −0.021 (0.007) −2.994* 0.217
*p < .05; MVC: maximum voluntary contraction; MVC and RT were natural log-transformed.
Table A.3
Best fitting linear regression models for right Crus I-extrastriate connectivity and force accuracy variability relationship.
Force accuracy variability Crus I-extrastriate connectivity during rest Term Estimate (SE) t(29) η2
Intercept 0.042 (0.004) 10.195* –
Group 0.015 (0.006) 2.385* 0.048
Age 0.004 (0.003) 1.238 0.012
PPI during rest 0.004 (0.002) 0.134 0.121
Group × PPI during rest −0.013 (0.004) −3.592* 0.252
Crus I-extrastriate connectivity during force Term Estimate (SE) t(29) η2
Intercept 0.047 (0.003) 15.357* –
Group 0.010 (0.006) 1.677 0.048
Age 0.004 (0.003) 1.216 0.012
PPI during force −0.005 (0.002) −3.077* 0.129
Group × PPI during force −0.012 (0.004) −3.332* 0.224
*p < .05; PPI: psychophysiological interaction.
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Table A.4
Clinical and demographic associations.
Variable CGG repeat length ICARS total score Reaction time Force accuracy Force accuracy variability PPI during force
Age† −0.066 0.258 0.096 −0.113 0.095 0.027
CGG repeat length†† – 0.562* 0.391 0.047 0.366 −0.308
ICARS total score†† – – 0.657* −0.187 0.244 −0.194
Reaction time† – – – −0.310 0.350* −0.231
Force accuracy† – – – – −0.109 −0.041
Force accuracy variability† – – – – – −0.370*
CGG: cytosine-guanine-guanine; ICARS: International Cooperative Ataxia Rating Scale; PPI reflects right Crus I – extrastriate connectivity during the force condition;
*p < .05; †Pearson correlations for combined healthy controls and premutation carriers; ††Spearman rank-order correlations for premutation carriers only.
Fig. A.1. Sensorimotor test stimuli and custom fiber-optic transducer (C; Neuroimaging Solutions, Gainesville, FL). Participants pressed when the red bar (A) turned
green (B) in order to move the white bar up to the target green bar. They were instructed to maintain their force level at the level of the green bar as steadily as
possible.
Fig. A.2. The relationship between force accuracy
variability and age varied as a function of group.
Post hoc analyses indicated that increased age was
associated with reduced force accuracy variability in
premutation carriers (i.e., more consistent perfor-
mance) and increased force accuracy variability in
healthy controls (i.e., less consistent performance).
Shaded regions reflect the 95% confidence interval
of a group-level linear fit.
W.S. McKinney, et al. NeuroImage: Clinical 27 (2020) 102332
9
Fig. A.3. BOLD activation contrast map of force compared to rest for healthy controls vs. FMR1 premutation carriers. Relative to FMR1 premutation carriers, healthy
controls demonstrated greater BOLD signal in extrastriate cortex during force relative to rest. MNI coordinates: [1, −86, 7]; k = 54 voxels; β = 0.909; p < .01,
α < 0.05.
Fig. A.4. Relationship between extrastriate BOLD activation (force minus rest) and age for healthy controls vs. FMR1 premutation carriers. Premutation carriers
showed increased extrastriate activation with age, while healthy controls showed reduced extrastriate activation with age. Shaded regions reflect the 95% confidence
interval of a group-level linear fit.
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Fig. A.5. Group differences in task-dependent right Crus I connectivity. A) Connectivity between right Crus I and a cluster in extrastriate cortex increased during
force relative to rest in controls, but decreased during force relative to rest in FMR1 premutation carriers. Blue indicates a larger force – rest interaction in controls
compared to premutation carriers. Orange indicates a larger force-rest change in premutation carriers. Whole-brain effects are displayed, and a significant cluster in
extrastriate cortex is outlined in black (voxel p < .005, cluster α < 0.03). B) Right Crus I seed region. C) Beta weights for force and rest PPI regressors were
estimated using a leave-one-subject-out method. Error bars represent the mean and bootstrap estimated±1 standard error.
Fig. A.6. Relationship between force accuracy
variability on Crus I-extrastriate functional con-
nectivity. Greater Crus I-extrastriate functional
connectivity was associated with lower force accu-
racy variability in premutation carriers but not in
healthy controls. Shaded regions reflect the 95%
confidence interval of a group-level linear fit.
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Appendix B. Supplementary data
Supplementary data to this article can be found online at https://doi.org/10.1016/j.nicl.2020.102332.
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